Arthurian Life Sciences

Arthurian Life Sciences was founded by renowned European biotechnology pioneer Professor Sir Chris Evans OBE to manage the Wales Life Sciences Investment Fund, a substantial £100 million initiative that forms a cornerstone of the Welsh Government's strategy to advance the life sciences sector. The fund targets investments in medical, pharmaceutical, and healthcare enterprises currently operating in Wales, while also seeking opportunities from throughout the UK, Europe, and globally that could deliver significant developmental and economic advantages to the Welsh region. With initial investment capabilities ranging from £500,000 to £5,000,000 and provisions for follow-on funding, Arthurian maintains flexibility to consider larger investment opportunities when appropriate circumstances arise.

The investment strategy employed by Arthurian demonstrates remarkable versatility across the risk spectrum, sub-sectors, company maturity levels, and funding requirements. This approach allows the fund to engage with organizations of varying sizes, from nascent startups to established corporations, while participating in both early and late-stage investment rounds. The fund's primary methodology centers on identifying and nurturing a select portfolio of high-potential companies, providing not just capital but comprehensive support to accelerate growth trajectories of promising Welsh enterprises and newly established ventures. Additionally, Arthurian actively works to attract non-Welsh companies and entrepreneurs to establish operations in Wales, creating a more robust life sciences ecosystem in the region.

With a comprehensive focus spanning the entire life sciences spectrum—including healthcare services, diagnostic technologies, medical devices, biotechnology innovations, and pharmaceutical developments—Arthurian positions itself as a versatile investor capable of evaluating opportunities across multiple specialized domains. The fund places particular emphasis on backing management teams with demonstrated expertise and impressive track records, recognizing that exceptional leadership often serves as the foundation for successful ventures. Arthurian actively cultivates international partnerships and collaborations, working to attract global co-investors to participate in Welsh life sciences opportunities, thereby amplifying the available capital and expertise while generating significant positive media coverage that enhances Wales' reputation as an emerging life sciences hub.

The Arthurian team has been strategically assembled with industry veterans specifically selected to create meaningful impact and generate excitement within the Welsh life sciences sector, both domestically and on the international stage. The fund maintains an active investment posture, with the capability to deploy capital immediately for qualifying opportunities. Prospective companies seeking investment are encouraged to submit applications with comprehensive business cases directly to Arthurian's dedicated inquiry channel. This investor-friendly approach reflects Arthurian's commitment to accessibility and its mission to transform Wales into a globally recognized center for life sciences innovation, creating economic growth while advancing critical healthcare solutions.